Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) is voluntarily recalling two lots of Riomet® (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet® (Metformin Hydrochloride Oral Solution) has been found to be contaminated (Scopulariopsis brevicaulis). The contamination was discovered during sample preparation for the Antimicrobial Preservative Effectiveness Testing (AMPET) being performed as part of the 12 month stability study interval.

Portable Compounding Cleanrooms



Aseptic Enclosures, manufacturers of Mobile Compounding Cleanrooms, in compliance with FDA, USP 797 & USP 800 standard. Many hospital pharmacies are undergoing major renovations to be in compliance with new standards. However, they must continue vital drug preparation without interruption. Aseptic Enclosures Mobile Cleanroom allows the hospital to maintain separate, on-site sterile drug compounding operations concurrent to a build-out.

Compounding Pharmacy

Charles River offers FDA-licensed products and cGMP-compliant services to maintain control and consistency in your compounding processes, from in-process testing to batch release.

Pharmacies that prepare individualized dosages of sterile drugs for patients must meet stringent requirements and standards to assure patient safety. Our FDA-licensed products and cGMP-compliant services for compounding pharmacists help maintain control, consistency and reduce risks associated with manufacturing in an aseptic environment.

Pharma Dogs Hunt Down Vaccine Disruptors in California

By Dr. Mercola

“Anti-Vaxxers Have Found a Way Around California’s Strict New Immunization Law. They Need to Be Stopped.” This hostile and derogatory headline was published in the Los Angeles Times November 8.1 The “loophole” they’re referring to is the use of medical vaccine exemptions written by physicians.

Pharmacy board lays down the law for compounded medicines


The pharmacy and medical boards have warned pharmacists not to compound medicines that are available commercially.

They say medicines should be compounded only if a commercial alternative is not available or is unsuitable for the patient.

Serialization In Practice: How Manufacturers Can Ensure Compliance

By Jerry Martin, pharmaceutical and life sciences consultant, PMMI, The Association for Packaging and Processing Technologies

Pills bar code

Pharmaceutical manufacturers cannot limit responsibility for DSCSA compliance to just the engineers and operators involved in processing and packaging.

Cleaning Validation for Medical Device Manufacturing

Why Get Cleaning Validation Support From Your Cleaner Supplier?


SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products Due to Potential Contamination

SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling all/the following lots of the below listed injectable products to the hospital level. The is a potential for the products to contain microbial contamination.

Pharmacist In Meningitis Case Gambled With Lives, Prosecutor Says

Glenn Chin, the supervisory pharmacist at the now-closed New England Compounding Center, departs federal court after attending the first day of his trial on Sept. 19. (Steven Senne/AP)


A pharmacist charged with murder in a meningitis outbreak that killed 76 people knew that mold and other bacteria were growing inside the filthy production rooms and that drugs shipped to customers were not sterile, but chose to do nothing, a federal prosecutor told jurors Friday.

FDA: Compounded Ocular Antibiotic May Cause Blindness

Compounded triamcinolone-moxifloxacin-vancomycin (TMV), a medication used for intraocular injection, may cause a rare, potentially blinding postoperative complication, according to the FDA.